Antithrombotic therapy for lower extremity artery disease: is more intense therapy required?

被引：1
|
作者：
Tazaki, Junichi [1 ]
Hasegawa, Koji [2 ]
Kimura, Takeshi [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
[2] Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Kyoto, Japan
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2020年 / 6卷 / 02期
关键词：
D O I：
10.1093/ehjcvp/pvz044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases', by G. Savarese et al., on page 86.
引用
收藏
页码：94 / 96
页数：3
相关论文
共 50 条
  • [41] Further Insights into the Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease Reply
    Krittanawong, Chayakrit
    Escobar, Johao
    Virk, Hafeez Ul Hassan
    Alam, Mahboob
    Virani, Salim
    Lavie, Carl J.
    Narayan, K. M. Venkat
    Sharma, Raman
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (07): : e138 - e138
  • [42] Antithrombotic therapy: less is more or the more the better?
    Pivato, Carlo Andrea
    Margonato, Alberto
    Godino, Cosmo
    EUROPACE, 2020, 22 (07): : 1142 - 1142
  • [43] Antithrombotic Therapy in Peripheral Artery Disease: Stepping in the Right Direction
    Kristin R. Hand
    Genevieve M. Hale
    American Journal of Cardiovascular Drugs, 2021, 21 : 523 - 534
  • [44] Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
    Lili Wei
    Enyong Su
    Weili Liu
    Wenlu Xing
    Xinyun Liu
    You Zhang
    Shan Wang
    Qianqian Cheng
    Datun Qi
    Chuanyu Gao
    BMC Cardiovascular Disorders, 20
  • [45] Future of antithrombotic therapy for heart failure with coronary artery disease
    Komiyama, Maki
    Agewall, Stefan
    Hasegawa, Koji
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (05) : E25 - E25
  • [46] Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease
    Luis Ferreiro, Jose
    Cequier, Angel R.
    Angiolillo, Dominick J.
    DIABETES & VASCULAR DISEASE RESEARCH, 2010, 7 (04): : 274 - 288
  • [47] Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
    Wei, Lili
    Su, Enyong
    Liu, Weili
    Xing, Wenlu
    Liu, Xinyun
    Zhang, You
    Wang, Shan
    Cheng, Qianqian
    Qi, Datun
    Gao, Chuanyu
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [48] Antithrombotic Therapy in Peripheral Artery Disease: Stepping in the Right Direction
    Hand, Kristin R.
    Hale, Genevieve M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (05) : 523 - 534
  • [49] Antithrombotic therapy in persons with coronary artery disease risk factors
    Kipshidze, N. N.
    Kamalova, M. N.
    Kakulia, M. S. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 185 - 185
  • [50] Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
    Bellettini, Elisa
    De Luca, Leonardo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
12345